Savara, Inc. (SVRA)

5.30 +0.14 (+2.71%) USD  |  NASDAQ  |  Feb 06, 16:00
5.295 0.00 (0.00%) After-Hours: 20:00
More

Savara SG&A Expense (TTM) : 37.38M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. 96.37M
ACADIA Pharmaceuticals, Inc. 523.36M
Alnylam Pharmaceuticals, Inc. 1.181B
BioMarin Pharmaceutical, Inc. 973.41M
Imunon, Inc. 7.011M